Evidence map›Paper›PMID 39687813›Full record

ArticleCureus2024

Assessment of Lead Exposure and Associated Risk Through Human Biomonitoring Among Urban Communities in Chennai, Southern India.

Jayachelvi Babu, Vigneswari Aravindalochanan, Saritha Sendhil, Kalpana Balakrishnan

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jayachelvi BabuPublic Health, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Vigneswari AravindalochananPublic Health, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Saritha SendhilPublic Health, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Kalpana BalakrishnanPublic Health, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLead exposure is a widely acknowledged risk to public health for children and adults. However, despite efforts to phase out major sources over the last several decades, estimates of the prevalence of blood lead exposures and associated risks remain poorly characterized in many low- and middle-income countries.

objectivesThis study aimed to determine blood lead levels (BLLs) and assess potential sources of lead exposure among urban communities in Chennai, Tamil Nadu. METHODOLOGY: We obtained blood samples from a cross-sectional sample of 300 healthy individuals aged between 18 and 60. BLLs were measured using inductively coupled plasma mass spectrometry (ICP-MS) following microwave digestion. A questionnaire was administered to gather information on potential sources of lead exposure. Multivariate regression models were then developed to identify major determinants of BLLs.

resultsThe mean BLL was 5.3 µg/dL with BLLs in 49% of the participants exceeding 5 µg/dL. Multiple linear regression analysis identified six predictor variables (low socio-economic status, age, male gender, proximity to industrial areas, using leaded paint and metallic cookware) that explained nearly 76% of the variance in the BLLs (F-value 82.39; p-value: < 0.001).

conclusionsThe results highlight the need for continued targeted interventions to reduce lead exposure, particularly among vulnerable populations in Chennai. Establishing greater capacities for regular biomonitoring and education on lead exposure prevention are recommended.

Indexed as

blood lead levelschennaihuman biomonitoringleadrisk assessmentsouthern india

Identifiers

PMID39687813
PMCPMC11647068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.